TrialThe Lancet. Infectious diseases2024

Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.

Luis Rivera Mejía et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.